Symbols

GOSS

Gossamer Bio·NASDAQ

--(--)

GOSS fundamentals

GOSS Q2 2025 Earnings

Gossamer Bio (GOSS) released its earnings on Aug 5, 2025: revenue was 11.49M (YoY -88.01%), beat estimates; EPS was -0.17 (YoY -177.27%), beat estimates.

Revenue / YoY

11.49M

-88.01%

EPS / YoY

-0.17

-177.27%

Report date

Aug 5, 2025

Earnings

EPS

Revenue

Revenue & Expenses

GOSS has released its 2025 Q4 earnings report, with revenue of 13.80M, reflecting a YoY change of 47.13%, and net profit of -47.24M, showing a YoY change of -43.02%. The Sankey diagram below clearly presents GOSS's revenue sources and cost distribution.

Key Indicators

Gossamer Bio (GOSS) key financial stats and ratios, covering profitability, financial health, and leverage.

Income Statement

Gossamer Bio (GOSS)'s revenue and profit trends over recent years, visualized with a waterfall chart to showcase the revenue-to-profit funnel.

Trend

Breakdown

Balance Sheet

Gossamer Bio (GOSS)'s asset and liability trends over recent years, visualized with a waterfall chart to illustrate changes in its asset-liability structure.

Trend

Breakdown

Cash Flow

Gossamer Bio (GOSS)'s cash flow trends over recent years, visualized with a waterfall chart to illustrate changes in its operating, investing, and financing cash flows.

Trend

Breakdown